Koninklijke Philips (PHG) Projected to Post Earnings on Wednesday

Koninklijke Philips (NYSE:PHG - Get Free Report) is projected to issue its Q4 2024 quarterly earnings results before the market opens on Wednesday, February 19th. Analysts expect the company to announce earnings of $0.55 per share and revenue of $5.10 billion for the quarter. Parties that wish to register for the company's conference call can do so using this link.

Koninklijke Philips (NYSE:PHG - Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.01). Koninklijke Philips had a negative net margin of 1.83% and a positive return on equity of 10.11%. On average, analysts expect Koninklijke Philips to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Koninklijke Philips Stock Down 11.5 %

PHG traded down $3.26 during trading on Wednesday, hitting $25.06. 2,787,735 shares of the company's stock traded hands, compared to its average volume of 658,064. The stock has a market capitalization of $23.55 billion, a price-to-earnings ratio of -59.65, a PEG ratio of 0.92 and a beta of 0.77. The company's 50 day simple moving average is $26.26 and its two-hundred day simple moving average is $28.18. Koninklijke Philips has a 12-month low of $19.55 and a 12-month high of $32.91. The company has a current ratio of 1.16, a quick ratio of 0.74 and a debt-to-equity ratio of 0.60.

Wall Street Analysts Forecast Growth

PHG has been the topic of a number of recent research reports. Jefferies Financial Group raised Koninklijke Philips from an "underperform" rating to a "hold" rating in a report on Tuesday, October 29th. StockNews.com downgraded shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a research report on Thursday, November 14th. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, Koninklijke Philips has a consensus rating of "Hold".

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.